9 reports of this reaction
3.6% of all ACETAMINOPHEN 500 MG reports
#3 most reported adverse reaction
DIZZINESS is the #3 most commonly reported adverse reaction for ACETAMINOPHEN 500 MG, manufactured by Allegiant Health. There are 9 FDA adverse event reports linking ACETAMINOPHEN 500 MG to DIZZINESS. This represents approximately 3.6% of all 253 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 500 MG who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is moderately reported among ACETAMINOPHEN 500 MG users, representing a notable but not dominant share of adverse events.
In addition to dizziness, the following adverse reactions have been reported for ACETAMINOPHEN 500 MG:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 9 FDA reports for ACETAMINOPHEN 500 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 3.6% of all adverse event reports for ACETAMINOPHEN 500 MG, making it one of the most commonly reported side effect.
If you experience dizziness while taking ACETAMINOPHEN 500 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.